日本引入灭活脊灰疫苗常规免疫后脊灰疫苗接种率与抗体血清阳性率
日本于2012年将口服脊灰疫苗改为两种灭活脊灰疫苗(cIPV和DTaP-sIPV)常规免疫。基于2011-2015年全国疫苗可预防疾病流行病学监测数据,评估接种率与脊灰病毒抗体血清阳性率。2011-2012年<1岁儿童接种率45.0-48.8%且抗体阳性率下降,引入IPV后2013-2015年<1岁儿童接种率升至95.5-100%,各型抗体阳性率升高。
要点
- 2012年日本将OPV改为cIPV和DTaP-sIPV常规免疫。
- 引入IPV前<1岁儿童脊灰疫苗接种率45.0-48.8%,抗体阳性率下降。
- 引入IPV后<1岁儿童接种率95.5-100%,3型抗体阳性率88.6-93.9%。
核心结论
- 引入IPV后,日本儿童脊灰疫苗接种率和抗体血清阳性率均保持高位。
研究设计与样本
- 基于2011-2015年全国疫苗可预防疾病流行病学监测(NESVPD)数据的横断面评估。
主要发现
- 2011-2012年调查的<1岁儿童脊灰疫苗接种率为45.0-48.8%,1型抗体阳性率51.7-65.9%、2型48.3-53.7%、3型15.0-29.3%,低于2009年调查水平。
- 2013-2015年调查的<1岁儿童接种率升至95.5-100%,1型抗体阳性率93.2-96.6%、2型93.1-100%、3型88.6-93.9%。
- <5岁儿童中,4剂IPV者3型抗体阳性率98.5%、GMT 247.4,显著高于2剂OPV者的72.5%和22.9。
- <5岁儿童中,4剂DTaP-sIPV或cIPV者3种脊灰病毒抗体阳性率96.5-100%、GMT 170.3-368.8,两者均高。
临床怎么用
- 日本经验提示,用IPV替代OPV可维持高接种率和高血清阳性率。
- 常规免疫引入IPV后需持续监测接种率和抗体水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Japan, the oral poliovirus vaccine (OPV) was changed to 2 types of inactivated poliovirus vaccine (IPV), the standalone conventional IPV (cIPV) and the Sabin-derived IPV combined with diphtheria-tetanus-acellular pertussis vaccine (DTaP-sIPV), for routine immunization in 2012. We evaluated polio vaccination coverage and the seroprevalence of poliovirus antibodies using data from the National Epidemiological Surveillance of Vaccine-Preventable Diseases (NESVPD) from 2011 to 2015. Several years before the introduction of IPV in 2012, OPV administration for children was refused by some parents because of concerns about the risk of vaccine-associated paralytic poliomyelitis. Consequently, in children aged <1 years who were surveyed in 2011-2012, polio vaccination coverage (45.0-48.8%) and seropositivity rates for poliovirus (type 1: 51.7-65.9%, type 2: 48.3-53.7%, and type 3: 15.0-29.3%) were decreased compared to those surveyed in 2009. However, after IPV introduction, the vaccination coverage (95.5-100%) and seropositivity rates (type 1: 93.2-96.6%, type 2: 93.1-100%, and type 3: 88.6-93.9%) increased among children aged <1 years in 2013-2015. In particular, seropositivity rates and geometric mean titers (GMTs) for poliovirus type 3 in <5-year-old children who received 4 doses of IPV (98.5% and 247.4, respectively) were significantly higher than in those who received 2 doses of OPV (72.5% and 22.9, respectively). Furthermore, in <5-year-old children who received 4 doses of either DTaP-sIPV or cIPV, the seropositivity rates and the GMTs for all 3 types of poliovirus were similarly high (96.5-100% and 170.3-368.8, respectively). Our findings from the NESVPD demonstrate that both the vaccination coverage and seropositivity rates for polio remained high in children after IPV introduction.
引用
- Satoh H, Tanaka-Taya K, Shimizu H, et al. Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan. Vaccine. 2019. PMID: 30827736. doi:10.1016/j.vaccine.2019.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。